Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Molecular Diagnostics : JMD|February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer BiomarkersHussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
Diabetes|October 5, 2007
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics studyHussam Al-Kateb, Andrew P Boright, Lucia Mirea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast CancerCynthia X Ma, Feng Gao, Jingqin Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast CancerCynthia X Ma, Vera Suman, Matthew P Goetz, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Clinical genomicist workstationMukesh K Sharma, Joshua Phillips, Saurabh Agarwal, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor PredispositionPeter N Fiorica, Lisa Golmard, Jung Kim, et al.
Pageof 3